Growth and survival signalling in B16F10 melanoma cells in 3D culture
- PMID: 20015052
- DOI: 10.1042/CBI20090147
Growth and survival signalling in B16F10 melanoma cells in 3D culture
Abstract
The two-way communication between the ECM (extracellular matrix) and the cytoplasm via the integrins has many functions in cancer cells, including the suppression of apoptosis. As cells in a 3D (three-dimensional) architecture resemble the in vivo situation more closely than do cells in more conventional 2D cultures, we have employed a substratum that prevents cell adhesion and induces cell aggregation to determine why highly metastatic B16F10 melanoma cells resist anoikis. We compared the behaviour of B16F10 cells in 2D [on tPS (tissue culture polystyrene)] and 3D culture {on polyHEMA [poly(2-hydroxyethylmethacrylate)]} configurations. For this, we analysed cell morphology, proliferation, apoptosis and the activation status of several proteins involved in cell proliferation and survival [RhoA, FAK (focal adhesion kinase), Akt, ERK1/2 (extracellular-signal-regulated kinase 1/2)]. B16F10 cells in 3D architecture were able to proliferate as cell aggregates for 3 days, after which the number of cells decreased. The normal Swiss 3T3 cells used as an anoikis-sensitive control did not proliferate on the anti-adhesive substratum. Rho A was activated in B16F10 aggregates throughout their time in culture, whereas it was not in Swiss 3T3 aggregates. An absence of apoptotic activity was correlated with the proliferation of B16F10 cells in aggregates: caspase 3 was significantly activated only after 3 days in culture on polyHEMA. FAK and Akt were transiently activated, and their inactivation was correlated with the induction of apoptosis. ERK1/2 were activated throughout the 3D culture. No survival protein was activated in Swiss 3T3 aggregates. Data obtained from cells in 3D culture suggest that B16F10 cells are resistant to anoikis through the activation of the FAK and Akt signalling pathways.
Similar articles
-
Akt and RhoA inhibition promotes anoikis of aggregated B16F10 melanoma cells.Cell Biol Int. 2012 Mar 1;36(3):311-9. doi: 10.1042/CBI20110069. Cell Biol Int. 2012. PMID: 22070397
-
An altered fibronectin matrix induces anoikis of human squamous cell carcinoma cells by suppressing integrin alpha v levels and phosphorylation of FAK and ERK.Apoptosis. 2007 Dec;12(12):2221-31. doi: 10.1007/s10495-007-0138-9. Apoptosis. 2007. PMID: 17879163
-
Methylselenol generated from selenomethionine by methioninase downregulates integrin expression and induces caspase-mediated apoptosis of B16F10 melanoma cells.J Cell Physiol. 2007 Aug;212(2):386-400. doi: 10.1002/jcp.21038. J Cell Physiol. 2007. PMID: 17348006
-
Signalling mechanisms of anoikis.Histol Histopathol. 2004 Jul;19(3):973-83. doi: 10.14670/HH-19.973. Histol Histopathol. 2004. PMID: 15168359 Review.
-
Radiobiology goes 3D: how ECM and cell morphology impact on cell survival after irradiation.Radiother Oncol. 2011 Jun;99(3):271-8. doi: 10.1016/j.radonc.2011.06.007. Epub 2011 Jun 23. Radiother Oncol. 2011. PMID: 21704412 Review.
Cited by
-
Therapeutic targeting of anoikis resistance in cutaneous melanoma metastasis.Front Cell Dev Biol. 2023 Apr 26;11:1183328. doi: 10.3389/fcell.2023.1183328. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37181747 Free PMC article. Review.
-
Functional involvement of β3-adrenergic receptors in melanoma growth and vascularization.J Mol Med (Berl). 2013 Dec;91(12):1407-19. doi: 10.1007/s00109-013-1073-6. Epub 2013 Aug 2. J Mol Med (Berl). 2013. PMID: 23907236
-
Therapeutic Application of Betalains: A Review.Plants (Basel). 2020 Sep 17;9(9):1219. doi: 10.3390/plants9091219. Plants (Basel). 2020. PMID: 32957510 Free PMC article. Review.
-
Maintenance of viability and proliferation of 3T3 cell aggregates incorporating fibroin microspheres into cultures.Cytotechnology. 2020 Aug;72(4):579-587. doi: 10.1007/s10616-020-00408-5. Epub 2020 Aug 14. Cytotechnology. 2020. PMID: 32797335 Free PMC article.
-
Deltex-3-like (DTX3L) stimulates metastasis of melanoma through FAK/PI3K/AKT but not MEK/ERK pathway.Oncotarget. 2015 Jun 10;6(16):14290-9. doi: 10.18632/oncotarget.3742. Oncotarget. 2015. PMID: 26033450 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous